Call: 800-447-9407

Fax: 302-288-6884

Webinar Packs
Customer Testimonials
Nice response to my questions and good suggestions for moving forward.

Some of these sessions are too basic - this one had a good mix of basic and details. The tips are helpful. One comment: a little more discussion regarding the use of Detection in FMEAs would be useful since many do not advocate its use. Thanks,

I especially liked that the Q&A session after the webinar was long enough to not only address my own questions but also to learn from the questions from the other participants in the webinar.

Very thorough understanding of the history/progression of the guidances, and very helpful evaluation of current and potential directions. Excellent presentation skills, very engaging.



Changes to the Medical Devices Directive 93/42/EEC

Global CompliancePanel
Global CompliancePanel
Training Options
 Duration: 60 Minutes  
Recorded Access recorded version only for one participant; unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)
Price: $295.00
Instructor David R. Dills
Product Id W13

Overview: This webinar will provide valuable assistance and guidance to all regulated companies that are preparing for CE Mark and ensuring compliance to MDD 93/42/EEC.

You might be interested in knowing that the European Commission has finally released a consolidated version of the revised Medical Devices Directive. The original Directive 93/42/EEC (published in 1993) was amended in late 2007 with the publication of Directive 2007/47/EC, but a combined version of those two Directives was not published at that time, making it difficult to interpret the changes Directive 2007/47/EC had on the original MDD. Originally created July 12, 1993 and mandatory since June 14, 1998, the Directive requires that companies wishing to sell medical devices within the EU must meet the requirements under the directive. The regulations under this mandate can vary from member country to member country concerning translation of key documents to other regulatory laws specific to that region. These additions supplement the set of harmonized standards put in place by the European Commission. These harmonized standards serve to free the flow of goods from one market to another within the EU Medical Device industry. Today, all medical devices sold in the EU must have the CE Marking affixed to demonstrate compliance to this directive. If your device falls within the scope of the Medical Devices Directive, then you must meet the essential requirements of that law.

Areas Covered in the Session:

  • Learn about the latest changes to the directive and impact on medical device manufacturers
  • Understand how to apply and use the Conformity Assessment Procedure
  • How to classify your medical device correctly
  • Learn how to use the Technical File correctly
  • How to apply the Declaration of Conformity and why this is critical for success
  • How ISO 13485 fits in with this process as a device company
  • Learn and understand the expectations for the Essential Requirements and the Certification Process
  • How is the Authorized Representative involved and why…and the ramifications of not meeting the requirements for CE Mark and 93/42/EEC for your company

Who will benefit: The employees who will benefit include:

  • All levels of Management for all departments and those who desire a better understanding or "refresh" overview
  • QA/QC/Compliance/Regulatory Affairs
  • Marketing & Sales
  • Engineering/Technical Services
  • Consultants
  • Operations and Manufacturing
David R. Dills, an independent Regulatory & Compliance Consultant with more than 22 years of hands-on experience and a proven track record within the FDA regulated industry, has an extensive regulatory and compliance background with Class I/II/III and IVD devices and managing and handling activities within the global regulatory and compliance landscape. He manages quality, regulatory and compliance projects with multiple competing priorities having a direct impact on site operations and commercial opportunities and develops strategies for governmental approval to introduce new products to market, provides guidance and direction on regulatory and compliance requirements and prepares/reviews worldwide submissions/dossiers/technical files and addresses requirements in the EU, Pacific Rim and The Americas regarding all aspects of device commercialization and especially FDA activities. Background encompasses broad capabilities in quality systems, validation, regulatory affairs, GxP compliance, auditing, interfacing with the regulatory agencies, managing enforcement actions and mitigating compliance exposure for companies, working with Notified Bodies, AR’s and demonstrates credible experience to maximize business performance in the devices arena. He strives to optimize business performance through proactive strategies to mitigate compliance exposure by providing strategic and tactical solutions that facilitate the achievement of regulatory milestones. David has been previously affiliated with well-known device manufacturers and service providers, including a well-known CRO and has served in various quality, regulatory and compliance management and advisory capacities with increasing responsibilities. David is an accomplished industry speaker and author of technical and compliance related topics published in industry journals. Please refer to his profile provided herein for additional information about his background.



Related Webinars:


Terms & Conditions | Privacy Policy | Legal Disclaimer | Unsubscribe

All rights are reserved © GlobalCompliancePanel.